Clinical Study

Autoimmune Diseases in Patients with Cushing’s Syndrome after Resolution of Hypercortisolism: Case Reports and Literature Review

Table 2

Demographic, anthropometric, hemodynamic, biochemical, and hormonal parameters at baseline and after a 24-month follow-up in patients with treated Cushing’s syndrome (CS) compared with the group of Cushing’s syndrome patients with posttreatment onset of autoimmune diseases (CS with AD).

Baseline24-month FU
CS () ACS with AD () BCS () CCS with AD () DA vs. CB vs. D

Age (years)0.030.03nsns
Sex (M/F)63/371/963/371/9
BMI (kg/m2)nsnsnsns
WC (cm)nsnsns0.01
Office SBP (mmHg)nsns0.010.01
Office DBP (mmHg)nsns0.010.02
HR (bpm)nsnsnsns
Creatinine (mg/dL)0.84 ± 0.41.05 ± 1.06ns0.95 ± 0.351.19 ± 1.24nsnsns
Na+ (mmol/L)nsnsnsns
K+ (mmol/L)nsnsnsns
Calcium (mg/dL)nsnsnsns
FG (mg/dL)nsnsnsns
Uric acid (mg/dL)nsnsnsns
TC (mg/dL)0.01nsns0.01
HDL-C (mg/dL)nsnsnsns
LDL-C (mg/dL)0.01ns0.030.02
TGL (mg/dL)0.01nsnsns
UFC (nmol/24 h)0.001ns0.0010.001
PC (nmol/L)0.001ns0.050.001
PC DXM (nmol/L)0.0010.0010.0010.001

BMI: body mass index; WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; Na+: serum sodium; K+: serum potassium; FG: fasting serum glucose; TC: total cholesterol; HDL-C: HDL cholesterol; LDL-C: LDL cholesterol; TGL: triglycerides; UFC: urinary free cortisol; PC: plasma cortisol; PC DXM: plasma cortisol postovernight 1 mg dexamethasone test.